| Dr James Michael Rynerson, MD | |
|
317 Seven Springs Way Ste 104, Brentwood, TN 37027-4576 | |
| (615) 637-9393 | |
| Not Available |
| Full Name | Dr James Michael Rynerson |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Location | 317 Seven Springs Way Ste 104, Brentwood, Tennessee |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1740285832 | NPI | - | NPPES |
| 180033104 | Other | KY | RAILROAD MEDIARE |
| 64281843 | Medicaid | KY | |
| 000000069310 | Other | KY | ANTHEM BCBS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | MD0000032268 (Tennessee) | Secondary |
| 207W00000X | Ophthalmology | 28184 (Kentucky) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr James Michael Rynerson, MD 405 S L Rogers Wells Blvd, Glasgow, KY 42141-1725 Ph: (270) 651-0439 | Dr James Michael Rynerson, MD 317 Seven Springs Way Ste 104, Brentwood, TN 37027-4576 Ph: (615) 637-9393 |
News Archive
Today, the National Institutes of Health will launch a new website with important educational resources for Coronavirus workers dealing with the spread of COVID-19.
Scientists at Karolinska Institutet and Miami University have discovered that cells in the pancreas cooperate - signal - in a way hitherto unknown. The discovery can eventually be of significance to the treatment of diabetes.
Hitachi High-Technologies Corporation (TOKYO:8036) today announced that cumulative shipments of the tabletop microscope TM-1000, launched in April 2005, have now surpassed 1,000 units.
The use of an evidence-based sedation protocol for endoscopic procedures improves the quality of practice and reduces the incidence of sedation-related adverse events, according to an AGA Institute Review of Endoscopic Sedation published in the August issue of Gastroenterology , the official journal of the American Gastroenterological Association (AGA) Institute.
Euthymics Bioscience, Inc., a privately held Delaware corporation, today announced that it has signed a non-binding Letter of Intent (LOI) to merge into and acquire DOV Pharmaceutical, Inc. (DOV), a Delaware corporation currently traded on the Pink Sheets, for $2.0 million in cash plus payment of certain of DOV's expenses. DOV believes that the contemplated $2.0 million cash payment to shareholders represents approximately $0.015 per share of DOV common stock. If the transaction is consummated, it is anticipated that DOV will be renamed Euthymics Bioscience, Inc.
› Verified 6 days ago
Robert Patrick Belihar, M.D., M.P.H. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 105 Westwood Pl Ste 350, Brentwood, TN 37027 Phone: 615-371-3000 Fax: 615-371-3089 | |
Alexandra T May, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1622 Westgate Cir, Brentwood, TN 37027 Phone: 629-255-2249 Fax: 629-255-4196 |